Compare IT & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IT | RVTY |
|---|---|---|
| Founded | 1979 | 1937 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Other Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 11.8B |
| IPO Year | 2010 | 1994 |
| Metric | IT | RVTY |
|---|---|---|
| Price | $143.52 | $89.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 16 |
| Target Price | ★ $220.38 | $111.87 |
| AVG Volume (30 Days) | ★ 1.3M | 908.7K |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.65 | 2.07 |
| Revenue | $2,021,441,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $3.64 | $6.34 |
| Revenue Next Year | $5.12 | $5.14 |
| P/E Ratio | ★ $15.34 | $43.76 |
| Revenue Growth | ★ 13.30 | N/A |
| 52 Week Low | $139.18 | $81.36 |
| 52 Week High | $451.73 | $118.30 |
| Indicator | IT | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 34.63 | 49.53 |
| Support Level | $142.32 | $88.73 |
| Resistance Level | $163.50 | $95.90 |
| Average True Range (ATR) | 7.02 | 2.96 |
| MACD | -0.54 | 0.93 |
| Stochastic Oscillator | 7.53 | 64.67 |
Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.